These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33389881)

  • 1. Prognostic Value of Differentially Expressed LncRNAs in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Tuluhong D; Dunzhu W; Wang J; Chen T; Li H; Li Q; Wang S
    Crit Rev Eukaryot Gene Expr; 2020; 30(5):447-456. PubMed ID: 33389881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis.
    Zhang S; Ma F; Xie X; Shen Y
    Medicine (Baltimore); 2020 Sep; 99(37):e21861. PubMed ID: 32925722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors.
    Rodrigues de Bastos D; Nagai MA
    PLoS One; 2020; 15(5):e0232284. PubMed ID: 32401758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
    Wu J; Cai Y; Zhao G; Li M
    J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
    Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
    Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer.
    Wang Y; Zhang G; Han J
    J Cell Biochem; 2019 Jun; 120(6):10513-10518. PubMed ID: 30635931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E; Wang H
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of long noncoding RNA in triple-negative breast cancer.
    Das PK; Siddika A; Rashel KM; Auwal A; Soha K; Rahman MA; Pillai S; Islam F
    Cancer Med; 2023 Oct; 12(20):20365-20379. PubMed ID: 37795578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
    Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
    Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-lncRNA immune prognostic signature for triple-negative breast cancer Running title: Immune lncRNAs predict prognosis of TNBC.
    Li YX; Wang SM; Li CQ
    Math Biosci Eng; 2021 May; 18(4):3939-3956. PubMed ID: 34198419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
    Zheng S; Yang L; Zou Y; Liang JY; Liu P; Gao G; Yang A; Tang H; Xie X
    J Hematol Oncol; 2020 Mar; 13(1):17. PubMed ID: 32138762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers.
    Liu M; Xing LQ; Liu YJ
    Medicine (Baltimore); 2017 Mar; 96(9):e6222. PubMed ID: 28248879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel long non-coding RNAs in triple-negative breast cancer.
    Shen X; Xie B; Ma Z; Yu W; Wang W; Xu D; Yan X; Chen B; Yu L; Li J; Chen X; Ding K; Cao F
    Oncotarget; 2015 Aug; 6(25):21730-9. PubMed ID: 26078338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance and mechanism of long noncoding RNA HAGLROS in triple negative breast cancer.
    Zheng L; He J; Li M; Yuan H; Li H; Hu F; Chen L; Tang W; Sheng M
    Pathol Res Pract; 2022 Mar; 231():153810. PubMed ID: 35182891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long non-coding RNA landscape in triple-negative breast cancer.
    Zhang W; Guan X; Tang J
    Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
    Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
    Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.